AzTrials
AzTrials

PhysiotherapyASTEROIDNCT06605040

Scientific Content Disseminated Via Social Media for Physiotherapists

A study testing Dissemination via Social Media and Dissemination via Email in people with Physiotherapy, run by Universidade Federal de Santa Maria at 1 site in Brazil.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study is designed to assess how effective social media is in disseminating scientific knowledge to physiotherapists in Brazil. The trial will include physiotherapists who treat at least three patients weekly and regularly use Instagram and WhatsApp. Read more about this study

Who is it for?
Any age
Conditions the study is for
Physiotherapy
What is being tested?
Dissemination via Social Media and Dissemination via Email
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteBrazil
Study dates
1 Nov 2024to Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Physiotherapists practicing in Brazil
  • Involvement in the rehabilitation of at least three patients per week
  • Having access to the social media platforms Instagram and WhatsApp at least once daily on most days of a typical week

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Federal University of Santa Maria

    Santa Maria, Rio Grande do Sul, 97105-900

Other trials in Brazil

About this study

Official title: Audiovisual Materials Disseminated Via Social Media Targeting Evidence-based Rehabilitation Implementation for Physiotherapists

This study is designed to assess how effective social media is in disseminating scientific knowledge to physiotherapists in Brazil. The trial will include physiotherapists who treat at least three patients weekly and regularly use Instagram and WhatsApp. Participants will be randomly assigned to one of two groups: the experimental group will receive scientific content through Instagram, while the control group will receive the same content via email. Both groups will engage with the material for 10 weeks.

The scientific content covers seven key topics related to physiotherapy, such as musculoskeletal and sport rehabilitation, and will be tailored to clinical practice. For the Instagram group, content will be shared via posts, stories, and reels, while the email group will receive summaries and links to full articles. The study aims to evaluate the impact of these interventions on participants\' engagement with scientific content and its application to clinical practice.

Key outcomes will include the effectiveness of knowledge dissemination, participant feedback on the audiovisual content, and qualitative insights from interviews. The study will follow a specific timeline, with reassessment three months after the intervention to gauge long-term effects. Data will be analyzed using both quantitative and qualitative methods, ensuring a comprehensive understanding of the intervention\'s reach and feasibility.

Read the detailed description

This protocol details a randomized, single-blind controlled trial to assess how effectively scientific content can be disseminated to Brazilian physiotherapists using social media (Instagram). The study will follow physiotherapists who treat at least three patients per week and use Instagram and WhatsApp regularly. These participants will be randomized into two groups: an experimental group receiving content via Instagram and a control group receiving the same information via email.

The study will focus on seven areas relevant to physiotherapy practice, including musculoskeletal rehabilitation, cardiovascular care, and women's health. The content, developed using scientific articles, will be shared daily over 10 weeks. For the Instagram group, the content will be presented through various formats like posts, stories, and reels, with visually engaging elements to boost retention. The email group will receive daily summaries of the articles, similar to a journal-style format.

To maintain participant engagement, both groups will receive weekly summaries, and participants will be assessed on how well they apply the scientific content in practice. The primary outcomes include the effectiveness of content dissemination, participant engagement, and knowledge retention, evaluated through surveys, interviews, and technical assessments. Qualitative interviews will explore participants' experiences, and the quality of the audiovisual materials used will be rated by participants.

The trial will last for 10 weeks, followed by an additional week for reassessment and a three-month follow-up. Data will be analyzed quantitatively to measure the reach and effectiveness of the interventions, with feasibility analyzed using the RE-AIM framework. Qualitative data will be analyzed through thematic analysis, ensuring an in-depth understanding of the intervention's success. This study aims to offer insights into the best methods for delivering scientific knowledge to healthcare professionals via digital platforms.

Conditions
Physiotherapy
Being tested
Dissemination via Social Media, Dissemination via Email
Keywords
Knowledge translation, continuous education, evidence-based practice

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dissemination via Social MediaOther

    Participants in the experimental group will follow a scientific Instagram profile where content will be shared. The profile will remain open, allowing permanent access to all posts. To optimize Instagram\'s algorithm, we will use an existing active profile. Any control group participants already following the profile will be removed upon allocation.

    For each selected article, we will create three presentations using Instagram features like carousel images and short videos, shared as posts, stories, and reels. This strategy will provide content for 30 weeks of daily posts. Each post will feature visually appealing graphics to convey scientific information and support evidence-based practice (EBP) competencies.

  • Dissemination via EmailOther

    The participant allocated to the control group will receive a different summary each day, along with a link to the full article. This strategy was chosen to replicate the approach used by scientific journals to disseminate new issues.

Study groups in NCT06605040
Study groupRoleWhat they receive
Social MediaExperimentalThe group will receive scientific content via social media
Receives: Other: Dissemination via Social Media
EmailActive comparatorThe group will receive scientific content via email
Receives: Other: Dissemination via Email

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Use of scientific information to make clinical decisions

    Participants should indicate their level using a scale 0-10 points (0 = I do not use; 10 = I only make clinical decisions using the best available evidence)

    Measured: Baseline and the end of treatment at 10 weeks

  2. Understanding of scientific information interpretation for application in clinical practice

    Participants should indicate their level using a scale 0-10 points (0 = I do not understand; 10 = I have a complete understanding to apply scientific findings in clinical practice)

    Measured: Baseline and the end of treatment at 10 weeks

  3. Motivation to search for scientific information that could support clinical decisions

    Participants should indicate their level using a scale 0-10 points (0 = I have no motivation; 10 = I am completely motivated)

    Measured: Baseline and the end of treatment at 10 weeks

  4. Importance of scientific information in making clinical decisions

    Participants should indicate their level using a scale 0-10 points (0 = No importance; 10 = Extremely important)

    Measured: Baseline and the end of treatment at 10 weeks

  5. Barriers to applying scientific findings

    Participants will describe their barriers to applying scientific findings in clinical practice and the number of barriers reported will be considered for analysis

    Measured: Baseline and the end of treatment at 10 weeks

  6. Evidence-Based Practice Questionnaire (EBPQ)

    The EBPQ evaluates EBP competencies and has 24 items scored using a 7-point Likert scale (1-7 points); mean of the items will be used for analysis

    Measured: Baseline and the end of treatment at 10 weeks

  7. Overcoming the reported barriers

    Participants will be asked whether the program helped to overcome the reported barriers (yes or no answer)

    Measured: End of treatment at 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Sep 2024
  2. Study start1 Nov 2024
  3. Primary completionJun 2025 (estimated)
  4. Study completionAug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06605040
Sponsor's protocol ID
4.033.967
Acronym
ASTEROID
Status last verified
Apr 2025
First submitted
15 Sep 2024
Last updated
8 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Dissemination via Social Media and Dissemination via Email in people with Physiotherapy, run by Universidade Federal de Santa Maria at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 8 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Use of scientific information to make clinical decisions (time frame: Baseline and the end of treatment at 10 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in